Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients.

被引:0
|
作者
Bringhen, Sara [1 ]
Larocca, Alessandra [2 ]
Rossi, Davide [3 ]
Romano, Alessandra
Genuardi, Mariella [2 ]
Ria, Roberto [3 ]
Leoni, Pietro [3 ]
Patriarca, Francesca [3 ]
Nozzoli, Chiara [3 ]
Guglielmelli, Tommasina [3 ]
Benevolo, Giulia [3 ]
Callea, Vincenzo [4 ]
Gentilini, Fabiana [3 ]
Elice, Francesca [3 ]
Olivero, Barbara [3 ]
Grasso, Mariella [3 ]
Falcone, Antonietta Pia [3 ]
Gottardi, Daniela [3 ]
Montefusco, Vittorio [3 ]
Allegra, Alessandro [3 ]
Rizzo, Manuela [3 ]
Leonardi, Giovanna [3 ]
Oddolo, Daniela [2 ]
Morabito, Fortunato [3 ]
Boccadoro, Mario [2 ]
Palumbo, Antonio [2 ]
机构
[1] GIMEMA, Italian Myeloma Network, Turin, Italy
[2] Univ Turin, AOU S Giovanni Battista, Myeloma Unit, Div Hematol, Turin, Italy
[3] GIMEMA, Italian Multiple Myeloma Network, Turin, Italy
[4] Inst Hematol Reggio Calabria, Reggio Di Calabria, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1248 / 1249
页数:2
相关论文
共 50 条
  • [1] Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Cavalli, Maide
    Genuardi, Mariella
    Ria, Roberto
    Gentili, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Rizzo, Vincenzo
    Cangialosi, Clotilde
    Musto, Pellegrino
    De Rosa, Luca
    Liberati, Anna Marina
    Grasso, Mariella
    Falcone, Antonietta P.
    Evangelista, Andrea
    Cavo, Michele
    Gaidano, Gianluca
    Boccadoro, Mario
    Palumbo, Antonio
    [J]. BLOOD, 2010, 116 (23) : 4745 - 4753
  • [2] Efficacy and safety of bortezomib in once weekly vs. twice weekly dosing in the treatment of multiple myeloma
    Ang, Kwan-Keat
    Beechinor, Ryan
    Quan, Michelle
    Tuscano, Joseph
    Rosenberg, Aaron
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S152 - S152
  • [3] Efficacy and safety of once-weekly bortezomib in multiple myeloma patients (vol 116, pg 4745, 2012)
    Bringhen, S.
    Larocca, A.
    Rossi, D.
    [J]. BLOOD, 2012, 120 (26) : 5250 - 5250
  • [4] Efficacy of Once-Weekly Bortezomib with Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma
    Gut, Natalia
    Yucebay, Filiz
    Dempsey, Jessica
    Li, Junan
    Benson, Don M., Jr.
    [J]. BLOOD, 2018, 132
  • [5] Efficacy and safety of a modified daratumumab/bortezomib/dexamethasone regimen using once weekly bortezomib in relapsed refractory multiple myeloma
    Abousaud, Marin
    Dressler, Emily
    Duda, Jessica
    Johnson, Emily
    Kennedy, LeAnne
    Rodriguez, Cesar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E150 - E151
  • [6] EFFICACY AND SAFETY OF WEEKLY INFUSION BORTEZOMIB IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Bringhen, S.
    Genuardi, M.
    Rossi, D.
    Petrucci, M.
    Andriani, A.
    Rizzi, R.
    Mele, G.
    Aitoro, G.
    Mettivier, V.
    Annibali, O.
    Rossini, F.
    Gentilini, P.
    Pavone, V.
    Cellini, C.
    Giuliani, N.
    Rauco, A.
    Baraldi, A.
    Dominietto, A.
    Capaldi, A.
    Pescosta, N.
    Rizzi, R.
    Nozza, A.
    Spadano, A.
    De Stefano, V.
    Holanek, M.
    Gaidano, G.
    Boccadoro, M.
    Palumbo, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 149 - 149
  • [7] Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients
    Takezako, Naoki
    Tokuhira, Michihide
    Sekiguchi, Naohiro
    Kizaki, Masahiro
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E142 - E143
  • [8] The Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients
    Takezako, Naoki
    Tokuhira, Michihide
    Sekiguchi, Naohiro
    Kurihara, Yuya
    Ito, Kenichi
    Kurimoto, Miwa
    Suzuki, Kenshi
    Kizaki, Masahiro
    [J]. BLOOD, 2016, 128 (22)
  • [9] Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
    Sidana, Surbhi
    Narkhede, Mayur
    Elson, Paul
    Hastings, Debbie
    Faiman, Beth
    Valent, Jason
    Samaras, Christy
    Hamilton, Kimberly
    Liu, Hien K.
    Smith, Mitchell R.
    Reu, Frederic J.
    [J]. PLOS ONE, 2017, 12 (03):
  • [10] EFFICACY, SAFETY AND TOLERANCE OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Ballina, B.
    Fuertes, M.
    Cerda, S.
    Martinez Robles, V
    Gonzalez, P.
    Rondon, F.
    Yacoubi, S.
    Rodriguez, J. A.
    Escalante, F.
    [J]. HAEMATOLOGICA, 2017, 102 : 94 - 95